R. Linke
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Neurology top 1%
- Surgery top 5%
- Co-authors
- Klaus TatschYaacov MatznerSimcha Urieli-ShovalSoheyl NoachtarIlonka EisensehrJohannes SchwarzDiane SeimetzYi‐Long Wu
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (45 papers)Alzheimer's disease research and treatments (16 papers)Colorectal Cancer Treatments and Studies (13 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
R. Linke
149 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 1.5k
- Oncology 1.4k
- Neurology 891
- Surgery 756
Countries citing papers authored by R. Linke
This map shows the geographic impact of R. Linke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Linke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Linke more than expected).
Fields of papers citing papers by R. Linke
This network shows the impact of papers produced by R. Linke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Linke. The network helps show where R. Linke may publish in the future.
Co-authorship network of co-authors of R. Linke
This figure shows the co-authorship network connecting the top 25 collaborators of R. Linke. A scholar is included among the top collaborators of R. Linke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Linke. R. Linke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 32 | |
| 3 | Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutationsbreakdown → | 331 |
| 4 | 5 | |
| 5 | The risk of non-sentinel metastases in primary breast cancer. | 2 |
| 6 | 4 | |
| 7 | 14 | |
| 8 | [Breast scintigraphy using 99mTc-sestamibi--use and limitations]. | 4 |
| 9 | Persistence of glomerular amyloid after autologous blood stem cell transplantation in Al-amyloidosis despite remission of nephrotic syndrome. | 1 |
| 10 | Diagnosis of the various amyloid diseases and new developments | 2 |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 5 | |
| 14 | 93 | |
| 15 | 53 | |
| 16 | 18 | |
| 17 | 12 | |
| 18 | 11 | |
| 19 | 20 | |
| 20 | Bestimmung von Serum-Insulin im Solid-Phase Enzym-Immunoassay unter Verwendung Antikörper-beschichteter Polystyrolgläschen | 5 |
About R. Linke
R. Linke is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 152 papers that have together received 5.2k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (45 papers), Alzheimer's disease research and treatments (16 papers) and Colorectal Cancer Treatments and Studies (13 papers). The work is most often cited by research in Neurology (891 citations), Oncology (1.4k citations) and Pulmonary and Respiratory Medicine (1.5k citations). R. Linke has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Klaus Tatsch, Yaacov Matzner, Simcha Urieli-Shoval, Soheyl Noachtar, Ilonka Eisensehr, Johannes Schwarz, Diane Seimetz, Yi‐Long Wu, Kazuhiko Nakagawa and Tony Mok. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.